Annual Retained Earnings:
$9.76B+$535.43M(+5.80%)Summary
- As of today, GSK annual retained earnings is $9.76 billion, with the most recent change of +$535.43 million (+5.80%) on December 31, 2024.
- During the last 3 years, GSK annual retained earnings has fallen by -$3.50 billion (-26.39%).
- GSK annual retained earnings is now -41.49% below its all-time high of $16.69 billion, reached on December 31, 2006.
Performance
GSK Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
$12.05B+$1.33B(+12.43%)Summary
- As of today, GSK quarterly retained earnings is $12.05 billion, with the most recent change of +$1.33 billion (+12.43%) on June 30, 2025.
- Over the past year, GSK quarterly retained earnings has increased by +$1.21 billion (+11.11%).
- GSK quarterly retained earnings is now -27.76% below its all-time high of $16.69 billion, reached on December 31, 2006.
Performance
GSK Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
GSK Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +5.8% | +11.1% |
| 3Y3 Years | -26.4% | +1.0% |
| 5Y5 Years | +15.5% | +47.3% |
GSK Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -26.4% | +30.7% | at high | +316.6% |
| 5Y | 5-Year | -26.4% | +30.7% | -9.1% | +316.6% |
| All-Time | All-Time | -41.5% | +217.3% | -27.8% | +235.3% |
GSK Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $12.05B(+12.4%) |
| Mar 2025 | - | $10.72B(+9.8%) |
| Dec 2024 | $9.76B(+5.8%) | $9.76B(-11.1%) |
| Sep 2024 | - | $10.98B(+1.2%) |
| Jun 2024 | - | $10.85B(+8.2%) |
| Mar 2024 | - | $10.02B(+8.6%) |
| Dec 2023 | $9.23B(+23.5%) | $9.23B(+7.7%) |
| Sep 2023 | - | $8.56B(+5.0%) |
| Jun 2023 | - | $8.16B(+16.7%) |
| Mar 2023 | - | $6.99B(-6.4%) |
| Dec 2022 | $7.47B(-43.7%) | $7.47B(+158.3%) |
| Sep 2022 | - | $2.89B(-75.7%) |
| Jun 2022 | - | $11.93B(+107.7%) |
| Mar 2022 | - | $5.74B(-56.7%) |
| Dec 2021 | $13.26B(+12.8%) | $13.26B(+26.4%) |
| Sep 2021 | - | $10.49B(+2.9%) |
| Jun 2021 | - | $10.19B(+10.3%) |
| Mar 2021 | - | $9.24B(-21.4%) |
| Dec 2020 | $11.76B(+39.2%) | $11.76B(+29.0%) |
| Sep 2020 | - | $9.12B(+11.5%) |
| Jun 2020 | - | $8.18B(+3.9%) |
| Mar 2020 | - | $7.88B(-6.8%) |
| Dec 2019 | $8.45B(+2403.9%) | $8.45B(+30.2%) |
| Sep 2019 | - | $6.49B(+281.8%) |
| Jun 2019 | - | -$3.57B(-12.3%) |
| Mar 2019 | - | -$3.18B(-766.1%) |
| Dec 2018 | -$366.80M(+94.1%) | -$366.80M(+86.5%) |
| Sep 2018 | - | -$2.71B(+23.3%) |
| Jun 2018 | - | -$3.54B(+60.3%) |
| Mar 2018 | - | -$8.91B(-42.4%) |
| Dec 2017 | -$6.26B(-43.0%) | -$6.26B(+12.8%) |
| Sep 2017 | - | -$7.18B(+5.6%) |
| Jun 2017 | - | -$7.60B(-24.0%) |
| Mar 2017 | - | -$6.13B(-40.1%) |
| Dec 2016 | -$4.38B(-757.1%) | -$4.38B(+48.5%) |
| Sep 2016 | - | -$8.51B(-4.7%) |
| Jun 2016 | - | -$8.13B(-52.9%) |
| Mar 2016 | - | -$5.32B(-898.3%) |
| Dec 2015 | $666.20M(+289.9%) | $666.20M(+165.0%) |
| Sep 2015 | - | -$1.03B(-217.3%) |
| Jun 2015 | - | $874.42M(-46.8%) |
| Mar 2015 | - | $1.64B(+150.8%) |
| Dec 2014 | -$350.83M(-107.7%) | -$3.23B(-67.6%) |
| Sep 2014 | - | -$1.93B(-614.1%) |
| Jun 2014 | - | -$270.16M(-133.9%) |
| Mar 2014 | - | $796.90M(-82.6%) |
| Dec 2013 | $4.57B | $4.57B(+2289.8%) |
| Sep 2013 | - | -$208.90M(-133.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $627.91M(-68.1%) |
| Mar 2013 | - | $1.97B(-51.4%) |
| Dec 2012 | $4.05B(-50.1%) | $4.05B(+137.5%) |
| Sep 2012 | - | $1.71B(-46.7%) |
| Jun 2012 | - | $3.20B(-49.2%) |
| Mar 2012 | - | $6.30B(-22.3%) |
| Dec 2011 | $8.11B(-21.8%) | $8.11B(+65.4%) |
| Sep 2011 | - | $4.90B(-32.2%) |
| Jun 2011 | - | $7.23B(-9.5%) |
| Mar 2011 | - | $7.99B(-23.0%) |
| Dec 2010 | $10.38B(-21.3%) | $10.38B(+12.8%) |
| Sep 2010 | - | $9.20B(+25.2%) |
| Jun 2010 | - | $7.35B(-29.0%) |
| Mar 2010 | - | $10.35B(-21.6%) |
| Dec 2009 | $13.19B(+41.8%) | $13.19B(+44.7%) |
| Sep 2009 | - | $9.12B(+30.1%) |
| Jun 2009 | - | $7.01B(+5.9%) |
| Mar 2009 | - | $6.62B(-28.8%) |
| Dec 2008 | $9.30B(-41.8%) | $9.30B(+27.3%) |
| Sep 2008 | - | $7.31B(-13.7%) |
| Jun 2008 | - | $8.47B(-25.5%) |
| Mar 2008 | - | $11.36B(-29.0%) |
| Dec 2007 | $16.00B(-4.1%) | $16.00B(+15.2%) |
| Sep 2007 | - | $13.89B(-11.5%) |
| Jun 2007 | - | $15.69B(+11.1%) |
| Mar 2007 | - | $14.13B(-15.3%) |
| Dec 2006 | $16.69B(+36.1%) | $16.69B(+36.1%) |
| Dec 2005 | $12.26B(+4.6%) | $12.26B(+4.6%) |
| Dec 2004 | $11.72B(+16.8%) | $11.72B(+16.8%) |
| Dec 2003 | $10.03B(+38.3%) | $10.03B(+38.3%) |
| Dec 2002 | $7.26B(-9.3%) | $7.26B(-9.3%) |
| Dec 2001 | $8.00B(-8.2%) | $8.00B(+12.3%) |
| Sep 2001 | - | $7.13B(+5.0%) |
| Jun 2001 | - | $6.79B(+8.8%) |
| Mar 2001 | - | $6.24B(-2.1%) |
| Dec 2000 | $8.72B(+49.2%) | $6.38B(+946.0%) |
| Dec 1999 | $5.85B(+443.0%) | - |
| Jun 1999 | - | $609.50M(-7.4%) |
| Dec 1998 | $1.08B(+113.5%) | - |
| Jun 1998 | - | $658.43M(-89.9%) |
| Dec 1997 | -$7.96B(+4.3%) | - |
| Dec 1996 | -$8.33B(-3.2%) | - |
| Dec 1995 | -$8.07B(>-9900.0%) | - |
| Jun 1995 | - | $6.54B |
| Jun 1994 | $0.00(-100.0%) | - |
| Jun 1993 | $5.44B(+4.3%) | - |
| Jun 1992 | $5.22B(+33.0%) | - |
| Jun 1991 | $3.92B | - |
FAQ
- What is GSK plc annual retained earnings?
- What is the all-time high annual retained earnings for GSK plc?
- What is GSK plc annual retained earnings year-on-year change?
- What is GSK plc quarterly retained earnings?
- What is the all-time high quarterly retained earnings for GSK plc?
- What is GSK plc quarterly retained earnings year-on-year change?
What is GSK plc annual retained earnings?
The current annual retained earnings of GSK is $9.76B
What is the all-time high annual retained earnings for GSK plc?
GSK plc all-time high annual retained earnings is $16.69B
What is GSK plc annual retained earnings year-on-year change?
Over the past year, GSK annual retained earnings has changed by +$535.43M (+5.80%)
What is GSK plc quarterly retained earnings?
The current quarterly retained earnings of GSK is $12.05B
What is the all-time high quarterly retained earnings for GSK plc?
GSK plc all-time high quarterly retained earnings is $16.69B
What is GSK plc quarterly retained earnings year-on-year change?
Over the past year, GSK quarterly retained earnings has changed by +$1.21B (+11.11%)